|
[1]Llovet JM, Ricci S, Mazzaferro V, et al.Sorafenib in advanced hepatocellular carcinoma[J].2008, 359 (4) :378-390.
|
|
[2]Cheng AL, Kang YK, Chen Z, et al.Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma:a phase III randomised, double-blind, placebo-controlled trial[J].Lancet Oncol, 2009, 10 (1) :25-34.
|
|
[3]程树群, 吴孟超, 陈汉.胸腺肽α1对原发性肝癌术后复发的影响[J].中华肝胆外科杂志, 2004, 10 (9) :592-593.
|
|
[4]李悦, 于雁.胸腺肽联合化疗治疗中晚期原发性肝癌的疗效观察[J].实用肿瘤学杂志, 2006, 20 (5) :403-404.
|
|
[5]罗羽宏, 梁中平, 李接兴.肝癌术后早期应用胸腺肽α1对T细胞亚群的影响[J].中国病理生理杂志, 2009, 25 (6) :1117-1121.
|